POLIVY

May 23, 2023

Abbvie-Genmab’s EPKINLY Approval for DLBCL Treatment: The First CD20XCD3 Bispecific Antibody

Apr 28, 2023

Roche’s CD79b ADC POLIVY: Attempt to Change DLBCL Treatment Space

Newsletter/Whitepaper